New injection shows promise for untreatable liver cancer
NCT ID NCT06310590
First seen Feb 03, 2026 · Last updated May 20, 2026 · Updated 16 times
Summary
This early-stage study tested a new drug called NRT6003 in 40 adults with liver cancer that cannot be surgically removed. The main goals were to check safety and see if the injection shrinks liver tumors. Researchers measured side effects and how long the tumors stayed under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Anhui Provincial Hospital
Hefei, Anhui, China
-
Henan Cancer Hospital
Zhengzhou, Henan, China
-
Hunan Provincial People's Hospital
Changsha, Hunan, China
-
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, China
-
The First Affiliated Hospital of Jinan University
Guangzhou, Guangdong, China
-
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
-
Zhongda Hospital, Southeast University
Nanjing, Jiangsu, 210009, China
-
Zhongshan Hospital, Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.